Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518539 · ClinicalTrials.gov registry record
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
A clinical trial of Cataract, sponsored by Newsom Eye & Laser Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05518539 is a study of Cataract that has completed, run by Newsom Eye & Laser Center. The registered enrollment target is 30 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05518539, a study of Cataract, has completed, sponsored by Newsom Eye & Laser Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate visual outcomes and quality of vision following bilateral implantation of the Clareon PanOptix intraocular lens (IOL) targeted for emmetropia.
Conditions Studied
Interventions
- DEVICE The Clareon™ PanOptix™ Trifocal (toric and non-toric models)
Study Locations (1)
Florida
- Newsom Eye & Laser Center - Sebring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2024-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05518539
The ClinicalTrials.gov registry entry for NCT05518539 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (87% lower). The listed sponsor is Newsom Eye & Laser Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which The Clareon™ PanOptix™ Trifocal (toric and non-toric models) is the first listed.
NCT05518539 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05518539 about?
NCT05518539 is a clinical study titled "Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens". To evaluate visual outcomes and quality of vision following bilateral implantation of the Clareon PanOptix intraocular lens (IOL) targeted for emmetropia.
What is the current status of trial NCT05518539?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2022-09-08. Estimated completion is 2024-06-14.
What conditions does trial NCT05518539 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT05518539?
The interventions under investigation include: The Clareon™ PanOptix™ Trifocal (toric and non-toric models) (DEVICE).
Who is sponsoring clinical trial NCT05518539?
This trial is sponsored by Newsom Eye & Laser Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05518539 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.